Ahmad Tarhini: Chatting with Patrick Hwu about the latest advances in melanoma management

Ahmad Tarhini, Director, Cutaneous Clinical and Translational Research at Moffitt Cancer Center and Research Institute, shared on LinkedIn:       .

“Chatting with Dr. Patrick Hwu about the latest advances in melanoma management including neoadjuvant immunotherapy as a new standard of care, triplet immuno-oncology combinations, and our efforts in biomarker development to better select the right treatment for our patients.”

Proceed to the video.
Source: Ahmad Tarhini/LinkedIn